George D. Yancopoulos
2019
In 2019, George D. Yancopoulos earned a total compensation of $20.7M as President and Chief Scientific Officer at Regeneron Pharmaceuticals, a 19% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,598,510 |
|---|---|
| Option Awards | $11,699,586 |
| Salary | $1,170,500 |
| Stock Awards | $4,983,226 |
| Other | $212,313 |
| Total | $20,664,135 |
Yancopoulos received $11.7M in option awards, accounting for 57% of the total pay in 2019.
Yancopoulos also received $2.6M in non-equity incentive plan, $1.2M in salary, $5M in stock awards and $212.3K in other compensation.
Rankings
In 2019, George D. Yancopoulos' compensation ranked 142nd out of 13,971 executives tracked by ExecPay. In other words, Yancopoulos earned more than 99.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 142 out of 13,971 | 99th |
Division Manufacturing | 53 out of 5,701 | 99th |
Major group Chemicals And Allied Products | 13 out of 2,200 | 99th |
Industry group Drugs | 11 out of 1,886 | 99th |
Industry Pharmaceutical Preparations | 10 out of 1,398 | 99th |
Source: SEC filing on April 24, 2020.
Yancopoulos' colleagues
We found four more compensation records of executives who worked with George D. Yancopoulos at Regeneron Pharmaceuticals in 2019.
2019
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2019
Andrew Murphy
Regeneron Pharmaceuticals
Executive Vice President, Research
2019
Robert Landry
Regeneron Pharmaceuticals
Chief Financial Officer
2019
Daniel Van Plew
Regeneron Pharmaceuticals
Executive Vice President and General Manager, Industrial Operations and Product Supply
News
Regeneron Pharmaceuticals Executive Vice President and General Manager, Industrial Operations and Product Supply Daniel Van Plew's 2021 pay rises 1% to $8.8M
April 21, 2022
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2020 pay jumps 531% to $135M
April 23, 2021
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2019 pay slips 19% to $21M
April 24, 2020
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2018 pay stays at $27M
April 26, 2019